These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22057504)

  • 1. Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease.
    Moore CM; Emberton M; Bown SG
    Lasers Surg Med; 2011 Sep; 43(7):768-75. PubMed ID: 22057504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
    Moore CM; Nathan TR; Lees WR; Mosse CA; Freeman A; Emberton M; Bown SG
    Lasers Surg Med; 2006 Jun; 38(5):356-63. PubMed ID: 16392142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer.
    Du KL; Mick R; Busch TM; Zhu TC; Finlay JC; Yu G; Yodh AG; Malkowicz SB; Smith D; Whittington R; Stripp D; Hahn SM
    Lasers Surg Med; 2006 Jun; 38(5):427-34. PubMed ID: 16788929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light.
    Yu G; Durduran T; Zhou C; Zhu TC; Finlay JC; Busch TM; Malkowicz SB; Hahn SM; Yodh AG
    Photochem Photobiol; 2006; 82(5):1279-84. PubMed ID: 16696593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy.
    Jankun J; Keck RW; Skrzypczak-Jankun E; Lilge L; Selman SH
    BJU Int; 2005 Jun; 95(9):1237-44. PubMed ID: 15892808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate.
    Xiao Z; Owen RJ; Liu W; Tulip J; Brown K; Woo T; Moore RB
    Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):106-14. PubMed ID: 20510305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of intraoperative photodynamic therapy with 5-aminolevulinic acid in dogs with prostate carcinoma.
    L'eplattenier HF; Klem B; Teske E; van Sluijs FJ; van Nimwegen SA; Kirpensteijn J
    Vet J; 2008 Nov; 178(2):202-7. PubMed ID: 17904397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy for prostate cancer--a review of current status and future promise.
    Moore CM; Pendse D; Emberton M
    Nat Clin Pract Urol; 2009 Jan; 6(1):18-30. PubMed ID: 19132003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP).
    Preise D; Scherz A; Salomon Y
    Photochem Photobiol Sci; 2011 May; 10(5):681-8. PubMed ID: 21258718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photosensitizers in prostate cancer therapy.
    Gheewala T; Skwor T; Munirathinam G
    Oncotarget; 2017 May; 8(18):30524-30538. PubMed ID: 28430624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses.
    Trachtenberg J; Weersink RA; Davidson SR; Haider MA; Bogaards A; Gertner MR; Evans A; Scherz A; Savard J; Chin JL; Wilson BC; Elhilali M
    BJU Int; 2008 Aug; 102(5):556-62. PubMed ID: 18494829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phototherapy in the treatment of bronchial cancer].
    Ninane V
    Rev Mal Respir; 1999 Nov; 16(4 Pt 2):633-9. PubMed ID: 10897826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy in dermatology.
    Ceburkov O; Gollnick H
    Eur J Dermatol; 2000; 10(7):568-75; discussion 576. PubMed ID: 11056436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.
    Verigos K; Stripp DC; Mick R; Zhu TC; Whittington R; Smith D; Dimofte A; Finlay J; Busch TM; Tochner ZA; Malkowicz S; Glatstein E; Hahn SM
    J Environ Pathol Toxicol Oncol; 2006; 25(1-2):373-87. PubMed ID: 16566729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy in urology: what can we do now and where are we heading?
    Bozzini G; Colin P; Betrouni N; Nevoux P; Ouzzane A; Puech P; Villers A; Mordon S
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):261-73. PubMed ID: 22959806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study.
    Raspagliesi F; Fontanelli R; Rossi G; Ditto A; Solima E; Hanozet F; Kusamura S
    Gynecol Oncol; 2006 Nov; 103(2):581-6. PubMed ID: 16793128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate.
    Dubuc C; Langlois R; Bénard F; Cauchon N; Klarskov K; Tone P; van Lier JE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2424-7. PubMed ID: 18329268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy.
    O'Connor AE; Gallagher WM; Byrne AT
    Photochem Photobiol; 2009; 85(5):1053-74. PubMed ID: 19682322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outline of the hundred-year history of PDT.
    Moan J; Peng Q
    Anticancer Res; 2003; 23(5A):3591-600. PubMed ID: 14666654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy for prostate cancer - A narrative review.
    Osuchowski M; Bartusik-Aebisher D; Osuchowski F; Aebisher D
    Photodiagnosis Photodyn Ther; 2021 Mar; 33():102158. PubMed ID: 33352313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.